Randomized trial: Oral Rimegepant for preventive treatment of migraine
21 Jan, 2021 | 01:04h | UTCOral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial – The Lancet (link to abstract – $ for full-text)
Commentary: Rimegepant bests placebo for preventing migraine – MedicalXpress
Against placebo? It would be interesting to know how this new drug works against other established treatments.